Rigel stock soars after FDA approves leukemia treatment, 2 days after receiving delisting notice

Shares of Rigel Pharmaceuticals Inc. RIGL, +1.86% soared 39.5% in premarket trading Friday, after the biotechnology company announced Food and Drug Administration approval of its Rezlidhia leukemia tr...

Actinium’s stock jumps 22% on new data for its acute myeloid leukemia therapy

Shares of Actinium Pharmaceuticals Inc. ATNM, +39.16% were up 22.8% in trading on Monday after the company met the primary endpoint in a Phase 3 clinical trial for its investigational treatment for re...